menu search

VRTX / The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High

The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High
Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday. Read More
Posted: Oct 12 2023, 15:17
Author Name: Investors Business Daily
Views: 112259

VRTX News  

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

By Zacks Investment Research
November 2, 2023

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $376.55, representing a +1.95% change from its previous close. more_horizontal

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

By Zacks Investment Research
October 27, 2023

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $355.28, denoting a -1.66% change from the preceding trading day. more_horizontal

This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024

By The Motley Fool
October 26, 2023

This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024

Large-cap growth stocks with wide economic moats and top-shelf management teams have outperformed this year. Vertex Pharmaceuticals, a rare disease sp more_horizontal

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

By Zacks Investment Research
October 23, 2023

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $367.66, denoting a +1.6% change from the preceding trading day. more_horizontal

Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again

By Zacks Investment Research
October 17, 2023

Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal

Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know

By Zacks Investment Research
October 16, 2023

Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $374, denoting a +0.81% change from the preceding trading day. more_horizontal

Is Vertex Pharmaceuticals Stock a Buy Now?

By The Motley Fool
October 15, 2023

Is Vertex Pharmaceuticals Stock a Buy Now?

Vertex's sales have been slowing down, and this year the top line may rise by less than 10%. The company has multiple assets in phase 3 trials, which more_horizontal

The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High

By Investors Business Daily
October 12, 2023

The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High

Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday. more_horizontal


Search within

Pages Search Results: